Human Coxsackie adenovirus receptor (CAR) expression in transgenic mouse prostate tumors enhances adenoviral delivery of genes

Prostate

Volumn 64, Issue 4, 2005, Pages 401-407

  Bao, Yunhua ^a   Peng, Weidan ^a   Verbitsky, Amy ^a   Chen, Jiping ^a   Wu, Lily ^b   Rauen, Katherine A ^c   Sawicki, Janet A ^a  

^a LANKENAU INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adenoviral vector; Coxsackie adenoviral receptor; Gene therapy; Prostate cancer; Transgenic mice

Indexed keywords

ADENOVIRUS VECTOR; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; LUCIFERASE; PROSTATE SPECIFIC ANTIGEN;

ADENOVIRUS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURFACE; CONTROLLED STUDY; GENE THERAPY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE TUMOR; PROTEIN EXPRESSION; REPORTER GENE; TRANSGENE; TUMOR CELL; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANIMALS; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GENE THERAPY; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PROSTATIC NEOPLASMS; RECEPTORS, VIRUS;

EID: 23944466203     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.20265     Document Type: Article

References (17)

1. Bergelson JM, Cunninghem JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 1997;275:1320-1323.
2. Tomko RP, Xu R, Philipson L. HCAR and MCAR: The human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci USA 1997;94:3352-3356.
3. Wickham TJ, Mathias P, Cheresh DA, Nemerow GR. Integrins αvβ3 and αvβ5 promote acenovirus internalization but not virus attachment. Cell 1993;73:309-319.
4. Bergelson JM, Kristhivas A, Celi L, Droguett G, Horwitz MS, Wickham T, Crowell RL, Finberg RW. The murine CAR homolog is a receptor for Coxsackie B viruses and adenoviruses. J Virol 1998;72:415-419.
5. v-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers. Gene Ther 1999;6:1520-1535.
6. Tallone T, Malin S, Samuelsson A, Wilbertz J, Miyahara M, Okamoto K, Poellinger L, Philipson L, Pettersson S. A mouse model for adenovirus gene delivery. Proc Natl Acad Sci USA 2001;98:7910-7915.
7. Kaner RJ, Worgall S, Leopold PL, Stolze E, Milano E, Hidaka C, Ramalingam R, Hackett NR, Singh R, Bergelson J, Finberg R, Falck-Petersen W, Crystal RG. Modification of the genetic program of human alveolar macrophages by adenovirus vectors in vitro is feasible but inefficient, limited in part by the low level of expression of the coxsackie/adenovirus receptor. Am J Respir Cell Mol Biol 1999;20:361-370.
8. Okegawa T, Li Y, Pong R-C, Bergelson JM, Zhou J, Hsieh J-T. The dual impact of Coxsackie and adenovirus receptor expression on human prostate cancer gene therapy. Cancer Res 2000;60:5031-5036.
9. Kim M, Zinn KR, Barnett BG, Sumerel LA, Krasnykh V, Curiel DT, Douglas JT. The therapeutic efficacy of adenoviral vectors for cancer gene therapy is limited by a low level of primary adenovirus receptors on tumour cells. Eur J Cancer 2002;38:1917-1926.
10. Wu L, Matherly J, Smallwood A, Adams JY, Billick E, Belldegrun A, Carey M. Chimeric PSA enhancers exhibit augmented activity in prostate cancer gene therapy vectors. Gene Ther 2001;8:1416-1426.
11. Greenberg NM, DeMayo F, Finegold MJ, Medina D, Tilley WD, Aspinall JO, Cunha GR, Donjacour AA, Matusik RJ, Rosen JM. Prostate cancer in a transgenic mouse. Proc Natl Acad Sci USA 1995;92:3439-3443.
12. Hogan B, Constantini F, Lacy E. Manipulating the mouse embryo. Cold Spring Harbor, NY: Cold Spring Harbor Press; 1986.
13. Rauen KA, Sudilovsky D, Le JL, Chew KL, Hann B, Weinberg V, Schmitt LD, McCormick F. Expression of the Coxsackie adenovirus receptor in normal prostate and in primary and metastatic prostate carcinoma: Potential relevance to gene therapy. Cancer Res 2002;62:3812-3818.
14. Peng W, Verbitsky A, Bao Y, Sawicki JA. Regulated expression of diphtheria toxin in prostate cancer cells. Mol Ther 2002;6:537-545.
15. Okabe M, Ikawa M, Kominami K, Nakanishi T, Nishimune Y. Green mice as a source of ubiquitous green cells. FEBS Lett 1997;407:313-319.
16. Lesche R, Groszer M, Gao J, Wang Y, Messing A, Sun H, Liu X, Wu H. Cre/loxP-mediated inactivation of the murine Pten tumor suppressor gene. Genesis 2002;32:148-149.
17. Ellwood-Yen K, Graeger TG, Wongvipat J, Iruela-Arispe ML, Zhang J, Matusik R, Thomas GV, Sawyers CL. Myc-driven murine prostate cancer shares molecular features with human tumors. Cancer Cell 2003;4:223-238.